Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance

Clinical and Experimental Hypertension

Volumn 38, Issue 4, 2016, Pages 370-374

  Ben Ali, Samir ^a   Belfki Benali, Hanen ^a   Ahmed, Decy Ben ^b   Haddad, Najet ^b   Jmal, Awatef ^c   Abdennebi, Monia ^c   Romdhane, Habiba Ben ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b Center of Basic Health Care of Ariana Essoghra   (Tunisia)

^c Mahmoud El Matri Hospital of Ariana   (Tunisia)

Author keywords

Abdominal obesity; apolipoprotein; hypertension; insulin resistance; menopause

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD PRESSURE MEASUREMENT; METABOLISM; MIDDLE AGED; OBESITY, ABDOMINAL; PHYSIOLOGY; PREVALENCE; PROCEDURES; RISK FACTOR; STATISTICAL MODEL; TUNISIA;

ADULT; AGED; ANTHROPOMETRY; APOLIPOPROTEINS B; BLOOD PRESSURE DETERMINATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LOGISTIC MODELS; MIDDLE AGED; OBESITY, ABDOMINAL; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; TUNISIA; WAIST CIRCUMFERENCE;

EID: 84965081816     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2015.1131286     Document Type: Article

References (38)

1. M.Cannoletta, A.Cagnacci Modification of blood pressure in postmenopausal women: role of hormone replacement therapy. Int J Womens Health 2014 Aug 11;6:745–57.
2. A.S.Go, D.Mozaffarian, V.L.Roger, et al. Heart disease and stroke statistics–2013 update: a report from the American heart association. Circulation 2013;127:e6–245.
3. S.M.Grundy, J.I.Cleeman, S.R.Daniels, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Circulation 2005;112:2735–52.
4. S.Ben Ali, A.Kallel, B.Ftouhi, et al. The -2548G/A LEP polymorphism is associated with blood pressure in Tunisian obese patients. Blood Press 2008;17:278–83.
5. R.Jemaa, S.Ben Ali, A.Kallel, et al. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with hypertension in a Tunisian population. Clin Biochem 2009;42:852–6.
6. J.M.Kim, T.H.Kim, H.H.Lee, et al. Postmenopausal hypertension and sodium sensitivity. J Menopausal Med 2014;20:1–6.
7. L.R.Krakoff Adiposity and risk for hypertension: does location matter? J Am Coll Cardiol 2014;64:1003–4.
8. Y.Matsui, K.Kario, J.Ishikawa, et al. Smoking and antihypertensive medication: interaction between blood pressure reduction and arterial stiffness. Hypertens Res 2005;28:631–8.
9. R.Dosi, N.Bhatt, P.Shah, R.Patell Cardiovascular disease and menopause. J Clin Diagn Res 2014;8:62–4.
10. J.N.Roemmich, D.M.Feda, A.M.Seelbinder, et al. Stress-induced cardiovascular reactivity and atherogenesis in adolescents. Atherosclerosis 2011;215:465–70.
11. H.Belfki, S.Ben Ali, H.Aounallah-Skhiri, et al. Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project. Public Health Nutr 2013;16:582–90.
12. M.Bowling, S.Oparil, F.Hage, et al. Sex hormones and vascular function. In: D.RKDubey (ed.). Sex Hormones. InTech: Rijeka, Croatia, 2012 (ISBN: 978953-307-856-4).
13. A.Perry, X.Wang, R.Goldberg, et al. Androgenic sex steroids contribute to metabolic risk beyond intra-abdominal fat in overweight/obese black and white women. Obesity (Silver Spring) 2013;21:1618–24.
14. Y.Zhou, X.Zhou, X.Guo, et al. Prevalence and risk factors of hypertension among pre- and post-menopausal women: a cross-sectional study in a rural area of northeast China. Maturitas 2015;80:282–7.
15. R.E.dos Santos, J.M.Aldrighi, J.R.Lanz, et al. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women. Gynecol Endocrinol 2005;21:295–301.
16. B.Arshi, M.Tohidi, A.Derakhshan, et al. Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population. J Hum Hypertens 2015;29:260–7.
17. M.R.Soules, S.Sherman, E.Parrott, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874–8.
18. W.H.OrganisationWorld Health. Physical status: the use and interpretation of anthropometry: Report of a WHO Expert Committee, WHO Technical Report Series, 1995; No 854, pp. 321–344. WHO: Geneva.
19. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on the detection, evaluation and treatment of high blood pressure (JNC VI). Arch Intern Med 1997;24:2413–46.
20. W.T.Friedewald, R.I.Levy, D.S.Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
21. D.R.Matthews, J.P.Hosker, A.S.Rudenski, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
22. S.Amigoni, P.Morelli, F.Parazzini, L.Chatenoud Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 2000;34:25–32.
23. A.Zanchetti, R.Facchetti, G.C.Cesana, et al. SIMONA participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005;23:2269–76.
24. J.S.Lee, K.Hayashi, G.Mishra, et al. Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses’ health study. J Atheroscler Thromb 2013;20:161–9.
25. E.Casiglia, V.Tikhonoff, S.Caffi, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens 2008;26:1983–92.
26. C.G.Lee, M.C.Carr, S.J.Murdoch, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009;94:1104–10.
27. J.C.Lovejoy, C.M.Champagne, L.DeJorge, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 2008;32:949–58.
28. B.E.Reubinoff, J.Wurtman, N.Rojansky, et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril 1995;64:963–8.
29. P.W.Wilson, R.B.D’Agostino, L.Sullivan, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162:1867–72.
30. J.E.Hall, A.A.da Silva, do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin and melanocortins. J Biol Chem 2010;85:17271–6.
31. A.Olszanecka, A.Posnik-Urbanska, K.Kawecka-Jaszcz, et al. Adipocytokines and BP, lipids and glucose metabolism in hypertensive perimenopausal women. Kardiolo Pol 2010;68:753–60.
32. D.Czarnecka, A.Posnik-Urbanska, K.Kawecka-Jaszcz, et al. Indices of autonomic nervous system activity in women with mild hypertension in the perimenopausal period. Kardiol Pol 2009;67:243–51.
33. V.G.DeMarco, A.R.Aroor, J.R.Sowers The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol 2014;10:364–76.
34. P.Chedraui, F.R.Pérez-López, G.S.Escobar, et al. Research Group for the Omega Women’s Health Project. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas 2014;79:86–90.
35. G.M.Reaven Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 2011;95:875–92.
36. A.Onat, G.Can, G.Hergenç, et al. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond) 2007;31:1119–125.
37. I.Boumaiza, A.Omezzine, J.Rejeb, et al. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients. Metab Syndr Relat Disord 2010;8:515–22.
38. D.Ganguli, N.Das, I.Saha, D.Chaudhuri, S.Ghosh, S.Dey Risk factors for hypertension in a population-based sample of postmenopausal women in Kolkata, West Bengal, India. Asia Pac J Public Health. 2013;25:388–97.